D&C Biotechnology

Seoul, South Korea

In Vitro Diagnostics Diagnostic Devices Diagnostics & Monitoring Biotech

D&C Biotechnology is a leading company in the global in vitro diagnostic device market, specializing in the development and production of next-generation urine analyzers. The company is committed to improving medical environments and protecting family health through innovative healthcare solutions. Their products focus on delivering faster, more accurate, easier, and safer diagnostic results. In addition to their flagship urine analyzer, D&C Biotechnology is actively engaged in research and development to advance digital healthcare, collaborating with partners to enhance the effectiveness of medical diagnostics. The company also emphasizes environmental, social, and governance (ESG) initiatives as a core part of its mission.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out D&C Biotechnology on @MedStartr Today #KidneyDisease #UrinaryTractInfection #Diabetes #GeneralHealth #InVitroDiagnostics #DiagnosticDevices #DiagnosticsScreeningMonitoring #Biotech #MedMo #MedStartrVentures

https://www.medstartr.ai/s/9agCPJ40RzU

Get Involved in D&C Biotechnology

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2021
Website: dncbiotechnology.com/

Disease Areas

Kidney Disease Urinary Tract Infection Diabetes General Health

Technologies

In Vitro DiagnosticsDiagnostic DevicesBiotechnologyAnalytical Instrumentation

🌐Website

What do you think of D&C Biotechnology?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.